
Servier and BC Partners enter exclusive negotiations for the sale of Biogaran
BC Partners is excited to support Biogaran in building a French-headquartered, industry-leading supplier of high-quality generic medication. Leveraging its deep…
Discover our latest insights and keep up to date with BC Partners’ news.
BC Partners is excited to support Biogaran in building a French-headquartered, industry-leading supplier of high-quality generic medication. Leveraging its deep…
Under BC Partners’ ownership, NAVEX has grown into the global leader in governance, risk and compliance software BC Partners to…
Launched in partnership with BMO Sponsor Finance, using its Great Lakes trade name for the fund High rate of investor…
GFL Environmental Inc. (NYSE: GFL) (TSX: GFL) (“GFL” or the “Company”) today announced that it has entered into a definitive…
Find out more about BC Partners’ investment in IMA, a global leader in the design and manufacture of automatic packaging…
Goldman Sachs Asset Management has agreed a more than €2bn deal to acquire drugmaker Synthon from BC Partners, according to…
Under BC Partners’ active ownership, Synthon has expanded rapidly, more than doubling EBITDA Transaction maintains BC Partners’ momentum in realisations,…
BC Partners’ Fahim Ahmed recently sat down with Bloomberg’s Swetha Gopinath to discuss BC’s significant exit momentum in the last…
We are delighted to share the annual BC Partners Sustainability Report for 2024. This year’s report reflects on the importance…
In a new series shining a light on BC Partners’ approach to operational excellence, we’re sitting down with members of…
In this macro-commentary from the BC Partners’ Credit team, Ted Goldthorpe and Mike Terwilliger, CFA, examine why they believe markets…
This strategic alliance represents a €40 million equity commitment from BC Partners Real Estate, which will enable the growth of…